Table of Content

1 DTaP Vaccine Market Overview
1.1 Product Overview and Scope of DTaP Vaccine
1.2 DTaP Vaccine Segment by Type
1.2.1 Global DTaP Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 DTaP Vaccine Segment by Application
1.3.1 Global DTaP Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global DTaP Vaccine Market Size Estimates and Forecasts
1.4.1 Global DTaP Vaccine Revenue 2016-2027
1.4.2 Global DTaP Vaccine Sales 2016-2027
1.4.3 DTaP Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 DTaP Vaccine Market Competition by Manufacturers
2.1 Global DTaP Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global DTaP Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global DTaP Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers DTaP Vaccine Manufacturing Sites, Area Served, Product Type
2.5 DTaP Vaccine Market Competitive Situation and Trends
2.5.1 DTaP Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest DTaP Vaccine Players Market Share by Revenue
2.5.3 Global DTaP Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 DTaP Vaccine Retrospective Market Scenario by Region
3.1 Global DTaP Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global DTaP Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America DTaP Vaccine Market Facts & Figures by Country
3.3.1 North America DTaP Vaccine Sales by Country
3.3.2 North America DTaP Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe DTaP Vaccine Market Facts & Figures by Country
3.4.1 Europe DTaP Vaccine Sales by Country
3.4.2 Europe DTaP Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific DTaP Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific DTaP Vaccine Sales by Region
3.5.2 Asia Pacific DTaP Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America DTaP Vaccine Market Facts & Figures by Country
3.6.1 Latin America DTaP Vaccine Sales by Country
3.6.2 Latin America DTaP Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa DTaP Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa DTaP Vaccine Sales by Country
3.7.2 Middle East and Africa DTaP Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global DTaP Vaccine Historic Market Analysis by Type
4.1 Global DTaP Vaccine Sales Market Share by Type (2016-2021)
4.2 Global DTaP Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global DTaP Vaccine Price by Type (2016-2021)

5 Global DTaP Vaccine Historic Market Analysis by Application
5.1 Global DTaP Vaccine Sales Market Share by Application (2016-2021)
5.2 Global DTaP Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global DTaP Vaccine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline DTaP Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GlaxoSmithKline DTaP Vaccine Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Sanofi Pasteur, Ltd.
6.2.1 Sanofi Pasteur, Ltd. Corporation Information
6.2.2 Sanofi Pasteur, Ltd. Description and Business Overview
6.2.3 Sanofi Pasteur, Ltd. DTaP Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanofi Pasteur, Ltd. DTaP Vaccine Product Portfolio
6.2.5 Sanofi Pasteur, Ltd. Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck DTaP Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck DTaP Vaccine Product Portfolio
6.3.5 Merck Recent Developments/Updates

7 DTaP Vaccine Manufacturing Cost Analysis
7.1 DTaP Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of DTaP Vaccine
7.4 DTaP Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 DTaP Vaccine Distributors List
8.3 DTaP Vaccine Customers

9 DTaP Vaccine Market Dynamics
9.1 DTaP Vaccine Industry Trends
9.2 DTaP Vaccine Growth Drivers
9.3 DTaP Vaccine Market Challenges
9.4 DTaP Vaccine Market Restraints

10 Global Market Forecast
10.1 DTaP Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of DTaP Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of DTaP Vaccine by Type (2022-2027)
10.2 DTaP Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of DTaP Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of DTaP Vaccine by Application (2022-2027)
10.3 DTaP Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of DTaP Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of DTaP Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global DTaP Vaccine Sales (K Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global DTaP Vaccine Sales (K Doses) Comparison by Application (2021-2027)
Table 3. Global DTaP Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers DTaP Vaccine Covered in This Study
Table 5. Global DTaP Vaccine Sales (K Doses) of Key Manufacturers (2016-2021)
Table 6. Global DTaP Vaccine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global DTaP Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global DTaP Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market DTaP Vaccine Average Price (US$/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers DTaP Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers DTaP Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global DTaP Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DTaP Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global DTaP Vaccine Sales by Region (2016-2021) & (K Doses)
Table 16. Global DTaP Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global DTaP Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America DTaP Vaccine Sales by Country (2016-2021) & (K Doses)
Table 19. North America DTaP Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America DTaP Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America DTaP Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe DTaP Vaccine Sales by Country (2016-2021) & (K Doses)
Table 23. Europe DTaP Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe DTaP Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe DTaP Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific DTaP Vaccine Sales by Region (2016-2021) & (K Doses)
Table 27. Asia Pacific DTaP Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific DTaP Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific DTaP Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America DTaP Vaccine Sales by Country (2016-2021) & (K Doses)
Table 31. Latin America DTaP Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America DTaP Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America DTaP Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa DTaP Vaccine Sales by Country (2016-2021) & (K Doses)
Table 35. Middle East and Africa DTaP Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa DTaP Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa DTaP Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global DTaP Vaccine Sales (K Doses) by Type (2016-2021)
Table 39. Global DTaP Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global DTaP Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global DTaP Vaccine Revenue Share by Type (2016-2021)
Table 42. Global DTaP Vaccine Price (US$/Dose) by Type (2016-2021)
Table 43. Global DTaP Vaccine Sales (K Doses) by Application (2016-2021)
Table 44. Global DTaP Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global DTaP Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global DTaP Vaccine Revenue Share by Application (2016-2021)
Table 47. Global DTaP Vaccine Price (US$/Dose) by Application (2016-2021)
Table 48. GlaxoSmithKline Corporation Information
Table 49. GlaxoSmithKline Description and Business Overview
Table 50. GlaxoSmithKline DTaP Vaccine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 51. GlaxoSmithKline DTaP Vaccine Product
Table 52. GlaxoSmithKline Recent Developments/Updates
Table 53. Sanofi Pasteur, Ltd. Corporation Information
Table 54. Sanofi Pasteur, Ltd. Description and Business Overview
Table 55. Sanofi Pasteur, Ltd. DTaP Vaccine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 56. Sanofi Pasteur, Ltd. DTaP Vaccine Product
Table 57. Sanofi Pasteur, Ltd. Recent Developments/Updates
Table 58. Merck Corporation Information
Table 59. Merck Description and Business Overview
Table 60. Merck DTaP Vaccine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 61. Merck DTaP Vaccine Product
Table 62. Merck Recent Developments/Updates
Table 63. Production Base and Market Concentration Rate of Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. DTaP Vaccine Distributors List
Table 66. DTaP Vaccine Customers List
Table 67. DTaP Vaccine Market Trends
Table 68. DTaP Vaccine Growth Drivers
Table 69. DTaP Vaccine Market Challenges
Table 70. DTaP Vaccine Market Restraints
Table 71. Global DTaP Vaccine Sales Forecast by Type (2022-2027) & (K Doses)
Table 72. Global DTaP Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 73. Global DTaP Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 74. Global DTaP Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 75. Global DTaP Vaccine Sales Forecast by Application (2022-2027) & (K Doses)
Table 76. Global DTaP Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 77. Global DTaP Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 78. Global DTaP Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 79. Global DTaP Vaccine Sales Forecast by Region (2022-2027) & (K Doses)
Table 80. Global DTaP Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 81. Global DTaP Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 82. Global DTaP Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of DTaP Vaccine
Figure 2. Global DTaP Vaccine Market Share by Type in 2020 & 2027
Figure 3. Inactivated Vaccine Product Picture
Figure 4. Live Attenuated Vaccine Product Picture
Figure 5. Global DTaP Vaccine Market Share by Application in 2020 & 2027
Figure 6. Government Institution
Figure 7. Private Sector
Figure 8. Other
Figure 9. Global DTaP Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global DTaP Vaccine Market Size 2016-2027 (US$ Million)
Figure 11. Global DTaP Vaccine Sales 2016-2027 (K Doses)
Figure 12. Global DTaP Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. DTaP Vaccine Sales Share by Manufacturers in 2020
Figure 14. Global DTaP Vaccine Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest DTaP Vaccine Players: Market Share by Revenue in 2020
Figure 16. DTaP Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global DTaP Vaccine Sales Market Share by Region (2016-2021)
Figure 18. Global DTaP Vaccine Sales Market Share by Region in 2020
Figure 19. Global DTaP Vaccine Revenue Market Share by Region (2016-2021)
Figure 20. Global DTaP Vaccine Revenue Market Share by Region in 2020
Figure 21. U.S. DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE DTaP Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of DTaP Vaccine by Type (2016-2021)
Figure 46. Sales Market Share of DTaP Vaccine by Application (2016-2021)
Figure 47. Sales Market Share of DTaP Vaccine by Application in 2020
Figure 48. Revenue Share of DTaP Vaccine by Application (2016-2021)
Figure 49. Revenue Share of DTaP Vaccine by Application in 2020
Figure 50. Manufacturing Cost Structure of DTaP Vaccine
Figure 51. Manufacturing Process Analysis of DTaP Vaccine
Figure 52. DTaP Vaccine Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed